Supporting networking and collaboration across the Life Science sector

We have set up the ‘AstraZeneca Exchange’ events as opportunities to bring together representatives from across the life science community in two of our strategic R&D hubs; Gothenburg, Sweden and Cambridge, UK.

The events are designed to offer discussion, knowledge-sharing and networking opportunities for our sector. They aim to explore some of the key issues we face and foster a greater level of collaboration across industry, biotech, academia and the public sector.


Our global headquarters moved to Cambridge in May 2016, building on our proud Medimmune heritage in the city. Over 2,500 AstraZeneca and MedImmune employees are already based in Cambridge and working to build strong connections within the local scientific community.

As a member of the Cambridge cluster and life-science ecosystem, we work with other organisations to ensure the significant economic and innovation of the cluster has the potential to grow its global competitiveness.

Since our move to Cambridge, we have delivered over 130 collaborations with our academic, healthcare and research partners to make life-changing discoveries.

The first AstraZeneca Exchange Cambridge event was held on 26 June 2017. This year’s event will take place on 21 June 2018 featuring an exciting line up of topics and speakers.

AstraZeneca Exchange Cambridge 2018

Key themes

  • Political and business themes shaping the life science sector’s future
  • Partnering and collaboration between biotech and pharma – success stories and capability development around drug discovery
  • AI and Big Data
  • Mentoring start-ups
  • Cambridge’s role as an important cluster for the sector globally


  • James Blitz, Whitehall Editor, Financial Times
  • Deborah DiSanzo, General Manager, IBM Watson Health and Non-Executive Director, AstraZeneca
  • Steve Jackson, Founder of KuDOS Pharmaceuticals
  • Elizabeth Croydon, Senior Clinical Director, Oncology, MSD Pharmaceuticals
  • Patrick Combes, Worldwide Technical Leader for Healthcare & Life Science, Amazon
  • Jackie Hunter, CEO Benevolent AI
  • Klaus Edvardsen, Vice President, Head of Oncology GMD, AstraZeneca
  • Rodolphe Grepinet, Executive Director, Corporate Development, AstraZeneca
  • Nick Brown - Head of AI & Data Science, AstraZeneca

AstraZeneca Exchange Cambridge 2017 Event

Please find a recap of the AstraZeneca Exchange 2017 Cambridge event here


AstraZeneca Gothenburg is home to approximately 2,400 AstraZeneca employees, with expertise and capabilities across all areas of pharmaceutical development: from discovery science to the finished medicines used in clinical trials and ultimately by patients. Through our Gothenburg site we have strong links to important hospitals and research institutions in Sweden, across the Nordic region and beyond

The AstraZeneca Exchange Gothenburg 2018 event was held on 29 May 2018.

Read more about AstraZeneca Exchange Gothenburg

Collaborate with us

We partner with like-minded science-led organisations that share an unrelenting focus on scientific quality, smart risk-taking, and good decision-making. 

Visit our partnering section to learn more.